###begin article-title 0
###xml 4 9 4 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD14 </italic>
###xml 95 117 95 117 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Chlamydia trachomatis </italic>
###xml 95 116 <span type="species:ncbi:813">Chlamydia trachomatis</span>
The CD14 functional gene polymorphism -260 C>T is not involved in either the susceptibility to Chlamydia trachomatis infection or the development of tubal pathology
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 73 78 73 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD14 </italic>
###xml 329 350 329 350 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Chlamydia pneumoniae </italic>
###xml 393 398 393 398 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD14 </italic>
###xml 510 525 510 525 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. trachomatis </italic>
###xml 329 349 <span type="species:ncbi:83558">Chlamydia pneumoniae</span>
###xml 510 524 <span type="species:ncbi:813">C. trachomatis</span>
###xml 554 559 <span type="species:ncbi:9606">women</span>
The functional polymorphism -260 C>T in the LPS sensing TLR4 co-receptor CD14 gene enhances the transcriptional activity and results in a higher CD14 receptor density. Individuals carrying the T/T genotype also have significantly higher serum levels of soluble CD14. The T allele of this polymorphism has recently been linked to Chlamydia pneumoniae infection. We investigated the role of the CD14 -260 C>T polymorphism in the susceptibility to and severity (defined as subfertility and/or tubal pathology) of C. trachomatis infection in Dutch Caucasian women.
###end p 3
###begin title 4
Methods
###end title 4
###begin p 5
###xml 14 19 14 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD14 </italic>
###xml 122 127 <span type="species:ncbi:9606">women</span>
###xml 177 182 <span type="species:ncbi:9606">women</span>
The different CD14 -260 C>T genotypes were assessed by PCR-based RFLP analysis in three cohorts: 1) A cohort (n = 576) of women attending a STD clinic, 2) a cohort (n = 253) of women with subfertility, and 3) an ethnically matched control cohort (n = 170). The following variables were used in the analysis: In cohort 1 the CT-DNA status, CT IgG serology status, self-reported symptoms and in cohort 2, the CT IgG serology status and the tubal status at laparoscopy.
###end p 5
###begin title 6
Results
###end title 6
###begin p 7
###xml 160 165 160 165 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD14 </italic>
###xml 292 297 <span type="species:ncbi:9606">women</span>
###xml 449 454 <span type="species:ncbi:9606">women</span>
###xml 567 572 <span type="species:ncbi:9606">women</span>
In the control cohort the CC, CT and TT genotype distribution was: 28.2%, 48.2%, and 23.5% respectively. No differences were found in the overall prevalence of CD14 -260 genotypes (28.1%, 50.7%, and 21.2%) in cohort 1 when compared to the control cohort. Also no differences were observed in women with or without CT-DNA, with or without serological CT responses, with or without symptoms, or in combinations of these three variables. In subfertile women with tubal pathology (cohort 2, n = 50) the genotype distribution was 28.0%, 48.0%, and 24.0% and in subfertile women without tubal pathology (n = 203), 27.6%, 49.3% and 23.2%. The genotype distribution was unchanged when CT IgG status was introduced in the analyses.
###end p 7
###begin title 8
Conclusion
###end title 8
###begin p 9
###xml 4 9 4 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD14 </italic>
###xml 177 192 177 192 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. trachomatis </italic>
###xml 177 191 <span type="species:ncbi:813">C. trachomatis</span>
The CD14 -260 C>T genotype distributions were identical in all three cohorts, showing that this polymorphism is not involved in the susceptibility to or severity of sequelae of C. trachomatis infection.
###end p 9
###begin title 10
Background
###end title 10
###begin p 11
###xml 0 10 0 10 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Chlamydia </italic>
###xml 86 107 86 107 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Chlamydia pneumoniae </italic>
###xml 143 155 143 155 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. psittaci </italic>
###xml 199 214 199 214 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. trachomatis </italic>
###xml 251 252 251 252 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 253 254 253 254 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 62 67 <span type="species:ncbi:9606">human</span>
###xml 86 106 <span type="species:ncbi:83558">Chlamydia pneumoniae</span>
###xml 143 154 <span type="species:ncbi:83554">C. psittaci</span>
###xml 199 213 <span type="species:ncbi:813">C. trachomatis</span>
Chlamydia species are related to a broad clinical spectrum of human disease including Chlamydia pneumoniae in lung and cardiovascular disease, C. psittaci in pulmonary emphysema and psittacosis, and C. trachomatis in ocular and urogenital infections [1-3].
###end p 11
###begin p 12
###xml 0 15 0 15 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. trachomatis </italic>
###xml 0 14 <span type="species:ncbi:813">C. trachomatis</span>
###xml 147 152 <span type="species:ncbi:9606">women</span>
C. trachomatis is the most prevalent sexually transmitted disease in Europe and the USA. Due to the mostly asymptomatic course of infection, these women will most likely not be treated resulting in an enhanced risk for the development of late complications, which include pelvic inflammatory disease (PID), ectopic pregnancy and tubal infertility.
###end p 12
###begin p 13
###xml 254 255 254 255 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 573 588 573 588 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. trachomatis </italic>
###xml 598 613 598 613 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. trachomatis </italic>
###xml 641 656 641 656 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. trachomatis </italic>
###xml 666 667 666 667 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 668 669 668 669 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 752 753 752 753 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 782 797 782 797 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. trachomatis </italic>
###xml 864 865 864 865 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 1104 1105 1104 1105 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 1106 1108 1106 1108 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 573 587 <span type="species:ncbi:813">C. trachomatis</span>
###xml 598 612 <span type="species:ncbi:813">C. trachomatis</span>
###xml 641 655 <span type="species:ncbi:813">C. trachomatis</span>
###xml 782 796 <span type="species:ncbi:813">C. trachomatis</span>
###xml 1011 1018 <span type="species:ncbi:9606">persons</span>
The female reproductive tract is a very complex system where many factors, including hormones, vaginal flora and immune mediators, combine to provide protection on the one hand, while on the other hand maintaining an environment suitable for conception [4]. Clear differences in the clinical course of infection have been described and are due to an interaction between environmental (e.g. co-infection), bacterial (e.g. virulence factors) and host factors (genetic differences between individuals). In previous studies no clear associations have been demonstrated between C. trachomatis serotype, C. trachomatis genotype, and the course of C. trachomatis infection[5,6], although differences in cytotoxicity for different serovars have been described[7] and an association between C. trachomatis serovar G and cervical squamous cell carcinoma has been suggested [8]. In addition, virulence gene expression studies, and genomic comparisons of strains, isolated from clearly symptomatic or asymptomatic infected persons, revealed no strong role for the CT bacterium in relation to the course of infection[9,10].
###end p 13
###begin p 14
###xml 138 153 138 153 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. trachomatis </italic>
###xml 247 257 247 257 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Chlamydia </italic>
###xml 267 269 267 269 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 138 152 <span type="species:ncbi:813">C. trachomatis</span>
A limited number of studies have recently demonstrated the influence of host genetic factors on the susceptibility to and the severity of C. trachomatis infection. Host factors including HLA-DQ and interleukin 10 (IL-10) have been associated with Chlamydia infection[11].
###end p 14
###begin p 15
###xml 174 176 174 176 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 188 195 188 195 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al. </italic>
###xml 261 263 261 263 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 315 317 315 317 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 318 320 318 320 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 422 424 422 424 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 473 478 473 478 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TLR4 </italic>
###xml 585 587 585 587 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 696 701 696 701 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TLR4 </italic>
###xml 825 827 825 827 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 256 260 <span type="species:ncbi:10090">mice</span>
###xml 285 289 <span type="species:ncbi:10090">mice</span>
###xml 340 345 <span type="species:ncbi:9606">human</span>
###xml 504 512 <span type="species:ncbi:9606">patients</span>
The Toll Like Receptor (TLR) family is a group of pattern recognition receptors, which recognise several microbial products, including bacterial cell wall components and DNA[12]. Poltorak et al. associated TLR4 with lipopolysaccharide (LPS) recognition in mice[13]. Further studies in mice corroborated these data [14,15], while studies in human demonstrated associations between TLR4 mutations and LPS hyporesponsiveness[16]. We did not observe an association between the TLR4 Asp299Gly polymorphism in patients with tubal pathology although the study population was relatively small[17]. The lack of association can be explained by recent publications showing that heterozygous carriage of the TLR4 Asp299Gly mutation does not affect LPS responsiveness and that only the rare homozygous carriers are less responsive to LPS[18].
###end p 15
###begin p 16
###xml 204 205 204 205 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 208 210 208 210 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 450 452 442 444 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
CD14 acts as a co-receptor for TLR4 and confers responsiveness to LPS, a component of the cell wall of most Gram-negative bacteria. CD14 forms a complex with LPS and the LPS-binding protein (LBP) (figure 1) [19]. Combined with TLR4 this complex induces NF-kappaB associated immune responses including the release of a broad spectrum of cytokines that include tumour necrosis factor alpha (TNF-alpha), IL-1, IL-6, and IL-8 to initiate immune response[20].
###end p 16
###begin p 17
###xml 0 17 0 17 <bold xmlns:xlink="http://www.w3.org/1999/xlink">CD14 localisation</bold>
CD14 localisation. Panel A: Membrane-bound CD14 (mCD14) complexed with TLR4 and the LBP - LPS complex. Panel B: Soluble CD14 (sCD14). Abbreviations: TLR: Toll-Like Receptor; LBP: LPS Binding Protein; LPS: Lipopolysaccharide; NF-kappaB: Nuclear Factor kappaB.
###end p 17
###begin p 18
###xml 27 32 27 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD14 </italic>
###xml 179 181 179 181 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 275 277 275 277 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 337 339 337 339 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 358 360 358 360 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 442 444 442 444 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 436 441 <span type="species:ncbi:9606">women</span>
The promotor region of the CD14 gene contains a single nucleotide polymorphism (SNP) at position -260. The -260 C>T genetic variation affects the binding of transcription factors[21] and has been associated with levels of sCD14 and inversely associated with serum IgE levels[20]. This SNP has been associated with myocardial infarction [22], Crohn's disease[23] and an increased susceptibility to develop chronic spondyloarthropathy in women[24].
###end p 18
###begin p 19
###xml 4 11 4 11 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al. </italic>
###xml 193 198 189 194 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD14 </italic>
###xml 242 256 238 252 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. pneumoniae </italic>
###xml 259 274 255 270 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. trachomatis </italic>
###xml 275 277 271 273 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 415 429 411 425 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. pneumoniae </italic>
###xml 475 477 471 473 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 490 495 486 491 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD14 </italic>
###xml 518 520 514 516 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 545 559 541 555 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. pneumoniae </italic>
###xml 569 571 565 567 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 604 626 600 622 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Chlamydia trachomatis </italic>
###xml 242 255 <span type="species:ncbi:83558">C. pneumoniae</span>
###xml 259 273 <span type="species:ncbi:813">C. trachomatis</span>
###xml 415 428 <span type="species:ncbi:83558">C. pneumoniae</span>
###xml 466 474 <span type="species:ncbi:9606">patients</span>
###xml 545 558 <span type="species:ncbi:83558">C. pneumoniae</span>
###xml 604 625 <span type="species:ncbi:813">Chlamydia trachomatis</span>
Eng et al. demonstrated that carriers of the T allele of this promotor polymorphism have a higher expression of both mCD14 and sCD14 and that TNFalpha production is increased in the homozygous CD14 -260 T carriers when stimulated with either C. pneumoniae or C. trachomatis [25]. In a recent article, Rupp and colleagues described an association between the mutant allele and an increased susceptibility to chronic C. pneumoniae infection in coronary artery disease patients[26]. Since the CD14 -260 C>T is functional[25] and is associated with C. pneumoniae infection[26], one could hypothesize that in Chlamydia trachomatis infection this polymorphism could influence the susceptibility to and severity of this most prevalent sexually transmitted bacterium which is associated with female infertility.
###end p 19
###begin p 20
###xml 43 48 43 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD14 </italic>
###xml 160 175 160 175 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. trachomatis </italic>
###xml 293 308 293 308 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. trachomatis </italic>
###xml 344 359 344 359 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. trachomatis </italic>
###xml 367 382 367 382 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. trachomatis </italic>
###xml 576 591 576 591 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. trachomatis </italic>
###xml 160 174 <span type="species:ncbi:813">C. trachomatis</span>
###xml 204 209 <span type="species:ncbi:9606">women</span>
###xml 223 228 <span type="species:ncbi:9606">women</span>
###xml 293 307 <span type="species:ncbi:813">C. trachomatis</span>
###xml 344 358 <span type="species:ncbi:813">C. trachomatis</span>
###xml 367 381 <span type="species:ncbi:813">C. trachomatis</span>
###xml 447 452 <span type="species:ncbi:9606">women</span>
###xml 576 590 <span type="species:ncbi:813">C. trachomatis</span>
Therefore, we investigated the role of the CD14 -260 C>T polymorphism in the susceptibility to and severity (defined as subfertility and/or tubal pathology) of C. trachomatis infection in Dutch Caucasian women. A cohort of women attending a STD clinic was used to assess the susceptibility to C. trachomatis infection, taking into account both C. trachomatis DNA and C. trachomatis IgG detection, symptoms and coinfections. A cohort of subfertile women with or without clinically well-defined tubal pathology was used to assess the role of CD14 in the severity of sequelae of C. trachomatis infection.
###end p 20
###begin title 21
Methods
###end title 21
###begin title 22
###xml 0 7 <span type="species:ncbi:9606">Patient</span>
Patient populations
###end title 22
###begin title 23
STD cohort
###end title 23
###begin p 24
###xml 260 261 260 261 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 792 807 792 807 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. trachomatis </italic>
###xml 884 886 884 886 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 0 5 <span type="species:ncbi:9606">Women</span>
###xml 272 277 <span type="species:ncbi:9606">women</span>
###xml 380 385 <span type="species:ncbi:9606">woman</span>
###xml 459 464 <span type="species:ncbi:9606">women</span>
###xml 792 806 <span type="species:ncbi:813">C. trachomatis</span>
Women of Dutch Caucasian (DC) origin (n = 576), under the age of 33 (range 14 to 33 years; median 22 years) and visiting the STD outpatient clinic in Amsterdam, The Netherlands, were included in this study (collection period: July 2001 - December 2004) (Table 1). All 576 women were consecutively included as the first part of a large prospective study. For every CT-DNA positive woman two consecutive CT-DNA negative controls were included in the study. The women were asked to sign an informed consent and to fill out a questionnaire, regarding their complaints at that moment, varying from increased discharge, having bloody discharge during and/or after coitus, recent abdominal pain (not gastrointestinal or menses related) and/or dysuria. A cervical swab was taken for the detection of C. trachomatis DNA (CT-DNA) by PCR (COBAS AMPLICOR; Hoffman - La Roche, Basel, Switzerland)[27].
###end p 24
###begin p 25
###xml 0 7 <span type="species:ncbi:9606">Patient</span>
Patient characteristics in the STD and subfertility cohorts.
###end p 25
###begin p 26
###xml 19 33 19 33 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. trachomatis</italic>
###xml 19 33 <span type="species:ncbi:813">C. trachomatis</span>
Abbreviations: CT: C. trachomatis; STD: sexually transmitted disease; TP: tubal pathology
###end p 26
###begin p 27
###xml 81 96 81 96 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. trachomatis </italic>
###xml 376 463 372 459 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Candida albicans, Neisseria gonorrhoea, Trichomonas vaginalis, Herpes simplex virus 1/2</italic>
###xml 634 639 630 635 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al</italic>
###xml 640 642 636 638 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 645 659 641 655 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N. gonorrhoea </italic>
###xml 714 720 710 716 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al </italic>
###xml 721 723 717 719 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 726 739 722 735 <italic xmlns:xlink="http://www.w3.org/1999/xlink">T. vaginalis </italic>
###xml 803 805 799 801 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 824 837 820 833 <italic xmlns:xlink="http://www.w3.org/1999/xlink">T. vaginalis </italic>
###xml 890 896 886 892 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al </italic>
###xml 897 899 893 895 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 902 914 898 910 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. albicans </italic>
###xml 958 970 954 966 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. albicans </italic>
###xml 1015 1017 1011 1013 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 81 95 <span type="species:ncbi:813">C. trachomatis</span>
###xml 97 99 <span type="species:ncbi:813">CT</span>
###xml 376 392 <span type="species:ncbi:5476">Candida albicans</span>
###xml 416 437 <span type="species:ncbi:5722">Trichomonas vaginalis</span>
###xml 439 461 <span type="species:ncbi:10298">Herpes simplex virus 1</span>
###xml 499 501 <span type="species:ncbi:813">CT</span>
###xml 726 738 <span type="species:ncbi:5722">T. vaginalis</span>
###xml 824 836 <span type="species:ncbi:5722">T. vaginalis</span>
###xml 902 913 <span type="species:ncbi:5476">C. albicans</span>
###xml 958 969 <span type="species:ncbi:5476">C. albicans</span>
Peripheral venous blood was collected for the analysis of IgG antibodies against C. trachomatis (CT) (Medac Diagnostika mbH, Hamburg, Germany). A titre of >/= 1:50 was considered positive. Samples with grey zone values, e.g. cut off +/- 10%, were repeated and considered positive when the result was positive or again within the grey zone. Infections with the microorganisms: Candida albicans, Neisseria gonorrhoea, Trichomonas vaginalis, Herpes simplex virus 1/2, may result in symptoms similar to CT infection. Infection status for these microorganisms was recorded. HSV 1/2 was detected according the methods described by Bruisten et al[28]. N. gonorrhoea was detected according methods described by Spaargaren et al [29]. T. vaginalis was cultured on Trichosel medium according standard procedures [30] and detection of T. vaginalis was according the methods described by van der Schee et al [31]. C. albicans was cultured on Chrom agar and detection of C. albicans was performed according standard procedures [30].
###end p 27
###begin title 28
Subfertility cohort
###end title 28
###begin p 29
###xml 245 247 245 247 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 406 416 406 416 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Chlamydia </italic>
###xml 59 64 <span type="species:ncbi:9606">women</span>
###xml 259 264 <span type="species:ncbi:9606">women</span>
###xml 393 401 <span type="species:ncbi:9606">patients</span>
The study was performed in 253 consecutive Dutch Caucasian women who visited the department of Obstetrics and Gynaecology of the Academisch Ziekenhuis Maastricht, The Netherlands, between December 1990 and November 2000 because of subfertility [32]. In these women a laparoscopy with tubal testing had been performed as part of their fertility work-up. Preoperatively blood was drawn from all patients for Chlamydia IgG antibody testing (CAT), and spare sera were cryopreserved.
###end p 29
###begin p 30
###xml 264 266 264 266 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 280 285 <span type="species:ncbi:9606">women</span>
###xml 413 418 <span type="species:ncbi:9606">women</span>
###xml 447 452 <span type="species:ncbi:9606">women</span>
Two independent investigators, who were unaware of the CAT results, scored the laparoscopy reports to assess the grade of tubal pathology. Tubal pathology was defined as extensive peri-adnexal adhesions and/or distal occlusion of at least one tube at laparoscopy [33]. Subfertile women who had no peri-adnexal adhesions and had patent tubes at laparoscopy served as negative controls. Based on these criteria, 50 women had tubal pathology and 203 women served as controls.
###end p 30
###begin p 31
###xml 18 33 18 33 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. trachomatis </italic>
###xml 131 133 131 133 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 245 247 245 247 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 261 276 261 276 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. trachomatis </italic>
###xml 18 32 <span type="species:ncbi:813">C. trachomatis</span>
###xml 261 275 <span type="species:ncbi:813">C. trachomatis</span>
###xml 414 419 <span type="species:ncbi:9606">women</span>
###xml 437 439 <span type="species:ncbi:813">CT</span>
###xml 469 471 <span type="species:ncbi:813">CT</span>
###xml 493 495 <span type="species:ncbi:813">CT</span>
###xml 509 514 <span type="species:ncbi:9606">women</span>
###xml 556 561 <span type="species:ncbi:9606">women</span>
###xml 577 579 <span type="species:ncbi:813">CT</span>
###xml 593 598 <span type="species:ncbi:9606">women</span>
IgG antibodies to C. trachomatis were detected with a species-specific MIF test (AniLabSystems, Finland), as described previously [32], with comparable sensitivity and specificity as compared to the IgG ELISA from Medac used for the STD cohort [34]. A positive C. trachomatis IgG MIF test was defined as a titre >/=1:32. Findings at laparoscopy were correlated with the MIF test results. Based on the MIF test, 41 women were found to be CT IgG positive, while 212 were CT IgG negative. Of the CT IgG positive women 28 (68.8%) had tubal pathology, while 22 women (10.4%) of the CT IgG negative women had tubal pathology.
###end p 31
###begin title 32
Healthy controls
###end title 32
###begin p 33
###xml 102 107 102 107 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD14 </italic>
A healthy Dutch Caucasian control group (n = 170) was included to assess the general frequency of the CD14 -260 genotypes in the Dutch Caucasian population.
###end p 33
###begin title 34
Immunogenetic analyses
###end title 34
###begin p 35
DNA Extraction
###end p 35
###begin title 36
STD cohort
###end title 36
###begin p 37
Eukaryotic DNA from PBMC was isolated using the isopropanol isolation method. In short: 100 mul PBMC in PBS were added to 600 mul L6 (Nuclisens Lysisbuffer, Organon Teknika, Boxtel, The Netherlands) and 1 mul glycogen (Roche Molecular Diagnostics, Almere, The Netherlands). The samples were incubated for 30 minutes at 65degreesC and left to cool at RT. An equal volume of cold (-20degreesC) isopropanol was added to the samples. The samples were then centrifuged (20 min at 20.000 G). The supernatant was discarded and the pellets were washed twice in 75% EtOH. The pellets were dissolved in T10 overnight (O/N) at 4degreesC and then stored at -20degreesC until further analysis.
###end p 37
###begin title 38
Subfertility cohort
###end title 38
###begin p 39
Genomic DNA was extracted out of the cryopreserved sera using High Pure PCR Template Preparation Kit (HPPTP kit) according to the manufacturer's instructions (Roche Molecular Biochemicals, Mannheim, Germany).
###end p 39
###begin title 40
Healthy controls
###end title 40
###begin p 41
Blood was collected in EDTA-tubes and stored at room temperature until the genomic DNA was extracted from peripheral blood leukocytes (PBMC) according to an in-house DNAzol (Invitrogen, The Netherlands) isolation procedure.
###end p 41
###begin title 42
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD14 </italic>
CD14 -260 C>T gene polymorphism
###end title 42
###begin p 43
###xml 37 42 37 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD14 </italic>
###xml 152 155 152 155 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hae</italic>
###xml 864 867 822 825 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hae</italic>
The C>T substitution in the proximal CD14 promoter GC box at position -260 from the translation start site (NCBI SNP CLUSTER ID:rs2569190) results in a HaeIII restriction site. We developed a PCR assay using the primers, 5' TCA CCT CCC CAC CTC TCT T 3' (sense) and 5' CCT GCA GAA TCC TTC CTG TT 3' (antisense) (Invitrogen Life Technologies, Breda, The Netherlands), flanking this restriction site. Amplification was performed using a thermal cycler Perkin-Elmer 9700 (Applied Biosystems, Forter City, CA, USA). The parameters were an initial denaturation at 95degreesC for 5 min, followed by 35 cycles: denaturation at 95degreesC for 30 s, annealing at 59degreesC for 30 s, and elongation at 72degreesC for 1 min. The final elongation was at 72degreesC for 7 min followed for a cooling to 4degreesC. The 107-bp fragments were digested overnight at 37degreesC with HaeIII (Invitrogen, The Netherlands) resulting in fragments that either were cut in two fragments of 83-bp and 24-bp (allele C) or were not restricted (T allele). These fragments were analyzed by electrophoresis on 4% low melting agarose gels (Tebu-Bio, The Netherlands) stained with ethidium bromide.
###end p 43
###begin title 44
Statistical analyses
###end title 44
###begin p 45
###xml 219 221 217 219 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2 </sup>
All groups were tested for Hardy-Weinberg equilibrium to check for Mendelian inheritance. Statistical analyses were performed using Instat Graphpad and SPSS version 11 (SPSS Inc., Chicago, IL, USA). Fisher exact and chi2 tests were used to test for differences in CD14 allele/genotype/carrier frequencies between the (sub)groups and p-values < 0.05 were considered statistically significant.
###end p 45
###begin title 46
Results
###end title 46
###begin p 47
###xml 76 81 76 81 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD14 </italic>
All genotype distributions assessed were in Hardy-Weinberg Equilibrium. The CD14 -260 C>T SNP was assessed in the STD, subfertility and control cohorts.
###end p 47
###begin title 48
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD14 </italic>
###xml 35 50 35 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. trachomatis </italic>
###xml 35 49 <span type="species:ncbi:813">C. trachomatis</span>
CD14 -260 in the susceptibility to C. trachomatis infection
###end title 48
###begin p 49
###xml 28 33 28 33 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD14 </italic>
###xml 67 82 67 82 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. trachomatis </italic>
###xml 111 116 111 116 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD14 </italic>
###xml 174 175 174 175 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 311 312 311 312 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 887 892 887 892 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD14 </italic>
###xml 67 81 <span type="species:ncbi:813">C. trachomatis</span>
###xml 232 234 <span type="species:ncbi:813">CT</span>
###xml 352 354 <span type="species:ncbi:813">CT</span>
###xml 368 370 <span type="species:ncbi:813">CT</span>
###xml 384 389 <span type="species:ncbi:9606">women</span>
###xml 400 402 <span type="species:ncbi:813">CT</span>
###xml 416 421 <span type="species:ncbi:9606">women</span>
###xml 459 461 <span type="species:ncbi:813">CT</span>
###xml 476 481 <span type="species:ncbi:9606">women</span>
###xml 510 512 <span type="species:ncbi:813">CT</span>
###xml 560 562 <span type="species:ncbi:813">CT</span>
###xml 593 595 <span type="species:ncbi:813">CT</span>
###xml 657 662 <span type="species:ncbi:9606">women</span>
###xml 768 770 <span type="species:ncbi:813">CT</span>
###xml 776 778 <span type="species:ncbi:813">CT</span>
To determine the effects of CD14 -260 C>T on the susceptibility to C. trachomatis infection, the prevalence of CD14 -260 C>T genotypes were assessed in the STD cohort (table 2). The overall genotype distribution was 28.1% CC, 50.7% CT, 21.2% TT. This distribution was comparable to the healthy controls (figure 2). The distribution was 28.8% CC, 50.0% CT, 21.2% TT in CT DNA positive women, while in CT DNA negative women the distribution was 27.8% CC, 51.0% CT, 21.2% TT. In women with or without serological CT responses the distribution was 30.4% CC, 49.3% CT, 20.3% TT and 26.7% CC, 51.5% CT, 21.7% TT, respectively. No differences could be observed in women with or without symptoms. Coinfection with other microorganisms or combinations of these four variables (CT DNA, CT serology, symptoms and microorganisms) did not introduce statistically significant differences or trends in CD14 genotype distributions.
###end p 49
###begin p 50
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD14 </italic>
###xml 0 71 0 71 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>CD14 </italic>genotype distribution in the STD, subfertility and control cohorts</bold>
CD14 genotype distribution in the STD, subfertility and control cohorts. Abbreviations: STD: sexually transmitted disease; HC: healthy controls
###end p 50
###begin p 51
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD14 </italic>
CD14 genotype distribution in the Dutch Caucasian STD cohort.
###end p 51
###begin p 52
###xml 0 15 0 15 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. trachomatis </italic>
###xml 154 167 154 167 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N. gonorrhoea</italic>
###xml 169 181 169 181 <italic xmlns:xlink="http://www.w3.org/1999/xlink">T. vaginalis</italic>
###xml 183 194 183 194 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. albicans</italic>
###xml 196 218 196 218 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H. simplex virus 1 &amp; 2</italic>
###xml 355 369 355 369 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. trachomatis</italic>
###xml 0 14 <span type="species:ncbi:813">C. trachomatis</span>
###xml 41 49 <span type="species:ncbi:9606">patients</span>
###xml 62 64 <span type="species:ncbi:813">CT</span>
###xml 169 181 <span type="species:ncbi:5722">T. vaginalis</span>
###xml 183 194 <span type="species:ncbi:5476">C. albicans</span>
###xml 196 214 <span type="species:ncbi:10298">H. simplex virus 1</span>
###xml 351 353 <span type="species:ncbi:813">CT</span>
###xml 355 369 <span type="species:ncbi:813">C. trachomatis</span>
C. trachomatis IgG positive and negative patients, divided in CT DNA (LCx) positive and negative and subdivided in coinfection with other microorganisms (N. gonorrhoea, T. vaginalis, C. albicans, H. simplex virus 1 & 2), symptoms (vulvovaginal discharge, abdominal pain, dysuria, bleeding during/after coitus) and lower abdominal pain. Abbreviations: CT: C. trachomatis; MO+: microorganism positive; LAP+: lower abdominal pain positive; Symp: symptoms positive
###end p 52
###begin title 53
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD14 </italic>
###xml 41 56 41 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. trachomatis </italic>
###xml 41 55 <span type="species:ncbi:813">C. trachomatis</span>
CD14 -260 in the severity of sequelae of C. trachomatis infection
###end title 53
###begin p 54
###xml 14 19 14 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD14 </italic>
###xml 59 74 59 74 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. trachomatis </italic>
###xml 267 268 267 268 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 524 525 524 525 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T3">3</xref>
###xml 587 602 587 602 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. trachomatis </italic>
###xml 59 73 <span type="species:ncbi:813">C. trachomatis</span>
###xml 123 128 <span type="species:ncbi:9606">women</span>
###xml 243 245 <span type="species:ncbi:813">CT</span>
###xml 300 305 <span type="species:ncbi:9606">women</span>
###xml 362 367 <span type="species:ncbi:9606">women</span>
###xml 409 411 <span type="species:ncbi:813">CT</span>
###xml 442 444 <span type="species:ncbi:813">CT</span>
###xml 544 546 <span type="species:ncbi:813">CT</span>
###xml 587 601 <span type="species:ncbi:813">C. trachomatis</span>
###xml 611 616 <span type="species:ncbi:9606">women</span>
The effect of CD14 -260 C>T on the severity of sequelae of C. trachomatis infection was assessed in a cohort of subfertile women with clinically well-defined tubal pathology. The overall genotype distribution in the cohort was 27.7% CC, 49.0% CT and 23.3% TT (figure 2). The genotype distribution in women with tubal pathology was similar to the distribution in women without tubal pathology (28.0% CC, 48.0% CT, 24.0% TT and 27.6% CC, 49.3% CT, 23.2% TT respectively) and to the distribution in the healthy controls (table 3). Introduction of CT IgG serology, with special attention to C. trachomatis positive women who did develop tubal pathology as compared to those who did not develop tubal pathology, did not alter the observed genotype distribution.
###end p 54
###begin p 55
CD14 genotype distribution in the Dutch Caucasian subfertility cohort.
###end p 55
###begin p 56
###xml 94 109 94 109 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. trachomatis </italic>
###xml 161 176 161 176 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. trachomatis </italic>
###xml 262 283 260 281 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Chlamydia trachomatis</italic>
###xml 51 56 <span type="species:ncbi:9606">women</span>
###xml 94 108 <span type="species:ncbi:813">C. trachomatis</span>
###xml 122 127 <span type="species:ncbi:9606">women</span>
###xml 161 175 <span type="species:ncbi:813">C. trachomatis</span>
###xml 258 260 <span type="species:ncbi:813">CT</span>
###xml 262 283 <span type="species:ncbi:813">Chlamydia trachomatis</span>
Distribution in the total cohort and subdivided in women with or without tubal pathology, and C. trachomatis IgG positive women with or without tubal pathology. C. trachomatis positivity defined as a titre >/= 1:32 (MIF). Abbreviations: TP: tubal pathology; CT: Chlamydia trachomatis.
###end p 56
###begin title 57
Discussion
###end title 57
###begin p 58
###xml 67 72 67 72 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD14 </italic>
###xml 158 173 158 173 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. trachomatis </italic>
###xml 244 245 244 245 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 366 381 366 381 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. trachomatis </italic>
###xml 158 172 <span type="species:ncbi:813">C. trachomatis</span>
###xml 366 380 <span type="species:ncbi:813">C. trachomatis</span>
We did not find an association between the functional upregulating CD14 -260 C>T polymorphism and the susceptibility to or subsequent severity of sequelae of C. trachomatis infection, as assessed in the STD and subfertility populations (figure 2). However, these results do not exclude that a still unknown CD14 expression decreasing SNP may influence the course of C. trachomatis infection.
###end p 58
###begin p 59
###xml 31 41 31 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Chlamydia </italic>
###xml 106 108 106 108 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 109 111 109 111 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
###xml 238 250 238 250 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S. minnesota</italic>
###xml 252 266 252 266 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N. gonorrhoea </italic>
###xml 267 269 267 269 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 294 306 294 306 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S. enterica </italic>
###xml 310 317 310 317 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli</italic>
###xml 318 320 318 320 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
###xml 329 336 329 336 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al. </italic>
###xml 427 429 427 429 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
###xml 555 557 555 557 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 558 560 558 560 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
###xml 648 650 648 650 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
###xml 238 250 <span type="species:ncbi:70803">S. minnesota</span>
###xml 294 305 <span type="species:ncbi:28901">S. enterica</span>
###xml 310 317 <span type="species:ncbi:110766|species:ncbi:562">E. coli</span>
Recent studies have shown that Chlamydia LPS is capable of inducing an inflammatory response through CD14[35,36], although the potency to induce an inflammatory response was 100 - 1000 times less when compared to the responses induced by S. minnesota, N. gonorrhoea [35] and the enterobacteria S. enterica and E. coli[36]. Heine et al. demonstrated that the CD14 associated inflammatory response was TLR4 but not TLR2 mediated[36]. These results are corroborated by studies showing the role of the CD14-TLR4-MD2 complex in intracellular signalling by LPS[13,37] and studies showing the dependency on CD14 of phagocytosis of Gram negative bacteria [38].
###end p 59
###begin p 60
###xml 65 80 65 80 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. trachomatis </italic>
###xml 270 272 270 272 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B39">39</xref>
###xml 341 343 341 343 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B40">40</xref>
###xml 356 358 356 358 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B41">41</xref>
###xml 626 628 626 628 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B40">40</xref>
###xml 629 631 629 631 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B41">41</xref>
###xml 738 740 738 740 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B41">41</xref>
###xml 945 947 945 947 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B41">41</xref>
###xml 1096 1098 1096 1098 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B42">42</xref>
###xml 1274 1276 1274 1276 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B43">43</xref>
###xml 1556 1562 1556 1562 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al.</italic>
###xml 1679 1681 1679 1681 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B44">44</xref>
###xml 1850 1852 1850 1852 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B45">45</xref>
###xml 1940 1942 1940 1942 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B46">46</xref>
###xml 65 79 <span type="species:ncbi:813">C. trachomatis</span>
###xml 323 331 <span type="species:ncbi:9606">patients</span>
###xml 1148 1152 <span type="species:ncbi:10090">mice</span>
###xml 1649 1653 <span type="species:ncbi:10090">mice</span>
###xml 1706 1711 <span type="species:ncbi:9606">human</span>
The absence of an association between CD14 and susceptibility to C. trachomatis infection might be explained by the compartmentalisation of TLR4. The differential expression of TLR4 has been described in immortalised cell-lines derived from the female urogenital tract [39] and recently demonstrated in cells isolated from patients by Pioli[40] and Fazeli[41]. TLRs 1 - 6 were found to be expressed in the epithelia of the female urogenital tract. TLR2 and TLR4 were the only Toll like receptors with a clear differential expression. Low expression in the lower urogenital tract and high expression in the upper genital tract[40,41]. The expression remained similar in all subjects irrespective of age or status of the reproductive cycle[41]. It is hypothesized that through this expression pattern TLR4 modulates immunological tolerance in the lower genital tract and induces host defence against ascending infection in the upper genital tract[41]. In the upper genital tract, Fazeli and colleagues found TLR4 positive vacuole like structures that seemed to be secreted from endocervical glands[42]. A secretory form of TLR4 has been described in mice, where the soluble TLR4 appears to inhibit LPS mediated signals, while at the same time sTLR4 mRNA is upregulated by LPS[43]. This may represent a feedback mechanism to prevent excessive responses to LPS in the endocervix, which can be seen as a boundary between the lower and upper genital tract. Further evidence for the regulation of immune responses to LPS by TLR4 is provided by the study of Harju et al., who demonstrated the intrauterine expression of TLR4 and endotoxin responsiveness in mice in the perinatal period [44]. mCD14 is expressed on human endometrial stromal cells but not on endometrial epithelial gland cells. The epithelial cells are dependent on sCD14 for LPS recognition [45]. Soluble CD14 is present in the cervical mucosa and may be present in the endometrium[46].
###end p 60
###begin p 61
###xml 163 168 163 168 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD14 </italic>
###xml 203 218 203 218 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. trachomatis </italic>
###xml 436 438 436 438 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B43">43</xref>
###xml 439 441 439 441 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B44">44</xref>
###xml 203 217 <span type="species:ncbi:813">C. trachomatis</span>
Combining the aforementioned studies with the knowledge that CD14 can signal through TLR4, it might be hypothesized that the absence of an association between the CD14 -260 SNP and the susceptibility to C. trachomatis infection might be due to the low expression or absence of TLR4 in the lower urogenital tract. In the upper genital tract, strict regulation of immune responses to LPS by TLR4 may inhibit CD14 signalling through TLR4 [43,44], thus limiting the influence of CD14 on the development of tubal pathology.
###end p 61
###begin p 62
###xml 95 97 95 97 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B47">47</xref>
###xml 154 161 154 161 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al. </italic>
###xml 207 228 207 228 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Chlamydia pneumoniae </italic>
###xml 312 314 312 314 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B48">48</xref>
###xml 369 384 369 384 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. trachomatis </italic>
###xml 207 227 <span type="species:ncbi:83558">Chlamydia pneumoniae</span>
###xml 369 383 <span type="species:ncbi:813">C. trachomatis</span>
However, this hypothesis does not take into account the ability of CD14 to signal through TLR2[47], nor does it take into account that the study of Netea et al. which demonstrated that non-LPS components of Chlamydia pneumoniae can stimulate cytokine production through TLR2 dependent, CD14 independent pathways[48] and that a similar mechanism may exist and stimulate C. trachomatis induced cytokine production in urogenital infections.
###end p 62
###begin p 63
###xml 275 277 275 277 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B49">49</xref>
Since TLR2 is involved in Chlamydia-induced TGF-beta, an anti-inflammatory cytokine with an important role in fibrosis, and thus very likely in post-infection tubal pathology, it might explain why CD14 polymorphisms may not severely impact the development of tubal pathology[49].
###end p 63
###begin p 64
###xml 9 16 9 16 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al. </italic>
###xml 99 114 99 114 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. trachomatis </italic>
###xml 235 237 235 237 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B50">50</xref>
###xml 238 240 238 240 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B51">51</xref>
###xml 275 282 275 282 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al. </italic>
###xml 300 314 300 314 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. pneumoniae </italic>
###xml 390 404 390 404 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. pneumoniae </italic>
###xml 486 500 486 500 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. pneumoniae </italic>
###xml 567 582 567 582 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. trachomatis </italic>
###xml 745 747 745 747 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B52">52</xref>
###xml 99 113 <span type="species:ncbi:813">C. trachomatis</span>
###xml 127 131 <span type="species:ncbi:10090">mice</span>
###xml 300 313 <span type="species:ncbi:83558">C. pneumoniae</span>
###xml 390 403 <span type="species:ncbi:83558">C. pneumoniae</span>
###xml 486 499 <span type="species:ncbi:83558">C. pneumoniae</span>
###xml 567 581 <span type="species:ncbi:813">C. trachomatis</span>
Darville et al. have demonstrated that TLR2 is an important mediator of innate immune responses in C. trachomatis infection in mice and plays an important role in early production of immune mediators and development of tubal pathology[50,51]. In a recent publication by Pitz et al. it was shown that C. pneumoniae is capable of activating endothelial cells by TLR2 as initial extracellular C. pneumoniae receptor, whereas NOD1 was shown to be a potent intracellular immune receptor for C. pneumoniae in endothelial cells. Further research may extend these results to C. trachomatis infections. Overall, the recognition of bacterial LPS involves a complex system of multiple receptors and a complex orchestration of protein-protein interactions [52].
###end p 64
###begin title 65
Conclusion
###end title 65
###begin p 66
###xml 51 56 51 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD14 </italic>
###xml 150 172 150 172 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Chlamydia trachomatis </italic>
###xml 267 282 267 282 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. trachomatis </italic>
###xml 371 386 371 386 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. trachomatis </italic>
###xml 449 464 449 464 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. trachomatis </italic>
###xml 150 171 <span type="species:ncbi:813">Chlamydia trachomatis</span>
###xml 267 281 <span type="species:ncbi:813">C. trachomatis</span>
###xml 371 385 <span type="species:ncbi:813">C. trachomatis</span>
###xml 449 463 <span type="species:ncbi:813">C. trachomatis</span>
Our study showed that the functional up-regulating CD14 -260 C>T SNP did neither influence the susceptibility to nor the severity of late sequelae of Chlamydia trachomatis infection. However, this does not exclude a prominent role for CD14 in the course of an active C. trachomatis infection and not yet described CD14 expression decreasing SNPs may affect the course of C. trachomatis infection profoundly. Further studies on the immunogenetics of C. trachomatis infection will provide more insight in the clear differences in the clinical course that this microorganism induces in individuals and lead to potential vaccine candidates.
###end p 66
###begin title 67
Competing interests
###end title 67
###begin p 68
The author(s) declare that they have no competing interests.
###end p 68
###begin title 69
Authors' contributions
###end title 69
###begin p 70
SO: Data acquisition, data/statistical analyses, drafting the manuscript
###end p 70
###begin p 71
JS: Sample collection, drafting the manuscript, critically revising for medical content
###end p 71
###begin p 72
JAL and JEDH: Sample collection, critically revising for medical content
###end p 72
###begin p 73
JSAF: Sample collection, critically revising for medical content
###end p 73
###begin p 74
JP: Data acquisition, data analyses
###end p 74
###begin p 75
ASP: Study design and conception, critically revising for immunogenetic content
###end p 75
###begin p 76
SAM: Study design, conception and coordination, critically revising for immunogenetic content
###end p 76
###begin p 77
###xml 0 58 0 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink">All authors contributed to writing of the final manuscript</italic>
All authors contributed to writing of the final manuscript.
###end p 77
###begin p 78
All authors read and approved the final manuscript
###end p 78
###begin title 79
Pre-publication history
###end title 79
###begin p 80
The pre-publication history for this paper can be accessed here:
###end p 80
###begin p 81

###end p 81
###begin title 82
Acknowledgements
###end title 82
###begin p 83
Sander Ouburg is an AstraZeneca Nederland BV fellow.
###end p 83
###begin p 84
Servaas A. Morre is supported by the Department of Internal Medicine of the VU University Medical Centre, the Netherlands.
###end p 84
###begin p 85
The authors are indebted to Prof. Cathrien Bruggeman, head of the department of Medical Microbiology, Academisch Ziekenhuis Maastricht, Maastricht, The Netherlands, for the serological testing of the subfertility cohort.
###end p 85
###begin p 86
###xml 44 66 44 66 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Chlamydia trachomatis </italic>
###xml 78 80 78 80 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B53">53</xref>
###xml 44 65 <span type="species:ncbi:813">Chlamydia trachomatis</span>
The ICTI consortium (Integrated approach to Chlamydia trachomatis Infections [53]) provides a broad specialized network for the multidisciplinary studies described.
###end p 86
###begin article-title 87
###xml 0 21 <span type="species:ncbi:813">Chlamydia trachomatis</span>
Chlamydia trachomatis infection in early neonatal period
###end article-title 87
###begin article-title 88
###xml 27 47 <span type="species:ncbi:83558">Chlamydia pneumoniae</span>
Association of circulating Chlamydia pneumoniae DNA with cardiovascular disease: a systematic review
###end article-title 88
###begin article-title 89
###xml 34 54 <span type="species:ncbi:83558">Chlamydia pneumoniae</span>
###xml 85 93 <span type="species:ncbi:9606">patients</span>
Smoking, season, and detection of Chlamydia pneumoniae DNA in clinically stable COPD patients
###end article-title 89
###begin article-title 90
Innate and adaptive immunity in female genital tract: cellular responses and interactions
###end article-title 90
###begin article-title 91
###xml 52 73 <span type="species:ncbi:813">Chlamydia trachomatis</span>
###xml 77 82 <span type="species:ncbi:9606">women</span>
Clinical manifestations of genital infection due to Chlamydia trachomatis in women: differences related to serovar
###end article-title 91
###begin article-title 92
###xml 0 21 <span type="species:ncbi:813">Chlamydia trachomatis</span>
###xml 46 54 <span type="species:ncbi:9606">patients</span>
###xml 133 139 <span type="species:ncbi:10090">murine</span>
Chlamydia trachomatis serovar E isolates from patients with different clinical manifestations have similar courses of infection in a murine model: host factors as major determinants of C trachomatis mediated pathogenesis
###end article-title 92
###begin article-title 93
###xml 90 111 <span type="species:ncbi:813">Chlamydia trachomatis</span>
###xml 146 165 <span type="species:ncbi:83560">Chlamydia muridarum</span>
Differences in growth characteristics and elementary body associated cytotoxicity between Chlamydia trachomatis oculogenital serovars D and H and Chlamydia muridarum
###end article-title 93
###begin article-title 94
###xml 13 34 <span type="species:ncbi:813">Chlamydia trachomatis</span>
Serotypes of Chlamydia trachomatis and risk for development of cervical squamous cell carcinoma
###end article-title 94
###begin article-title 95
###xml 37 58 <span type="species:ncbi:813">Chlamydia trachomatis</span>
Analysis of genetic heterogeneity in Chlamydia trachomatis clinical isolates of serovars D, E and F by Amplified Fragment length Polymorphism
###end article-title 95
###begin article-title 96
###xml 73 94 <span type="species:ncbi:813">Chlamydia trachomatis</span>
###xml 135 143 <span type="species:ncbi:9606">patients</span>
Interrelationship between polymorphisms of incA, fusogenic properties of Chlamydia trachomatis strains, and clinical manifestations in patients in The Netherlands
###end article-title 96
###begin article-title 97
###xml 63 84 <span type="species:ncbi:813">Chlamydia trachomatis</span>
HLA DQ alleles and interleukin-10 polymorphism associated with Chlamydia trachomatis-related tubal factor infertility: a case-control study
###end article-title 97
###begin article-title 98
Toll-like receptors
###end article-title 98
###begin article-title 99
###xml 52 56 <span type="species:ncbi:10090">mice</span>
Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene
###end article-title 99
###begin article-title 100
Tlr4: central component of the sole mammalian LPS sensor
###end article-title 100
###begin article-title 101
The role of toll-like receptor (TLR) 2 and TLR4 in the host defense against disseminated candidiasis
###end article-title 101
###begin article-title 102
###xml 67 73 <span type="species:ncbi:9606">humans</span>
TLR4 mutations are associated with endotoxin hyporesponsiveness in humans
###end article-title 102
###begin article-title 103
###xml 112 133 <span type="species:ncbi:813">Chlamydia trachomatis</span>
The role that the functional Asp299Gly polymorphism in the toll-like receptor-4 gene plays in susceptibility to Chlamydia trachomatis-associated tubal infertility
###end article-title 103
###begin article-title 104
Monocytes Heterozygous for the Asp299Gly and Thr399Ile Mutations in the Toll-like Receptor 4 Gene Show No Deficit in Lipopolysaccharide Signalling
###end article-title 104
###begin article-title 105
CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein
###end article-title 105
###begin article-title 106
A Polymorphism* in the 5' flanking region of the CD14 gene is associated with circulating soluble CD14 levels and with total serum immunoglobulin E
###end article-title 106
###begin article-title 107
###xml 66 71 <span type="species:ncbi:9606">human</span>
Sp1 is a critical factor for the monocytic specific expression of human CD14
###end article-title 107
###begin article-title 108
C(-260)-->T polymorphism in the promoter of the CD14 monocyte receptor gene as a risk factor for myocardial infarction
###end article-title 108
###begin article-title 109
###xml 61 69 <span type="species:ncbi:9606">patients</span>
Interaction of polymorphisms in the CARD15 and CD14 genes in patients with Crohn disease
###end article-title 109
###begin article-title 110
###xml 40 48 <span type="species:ncbi:9606">patients</span>
CD14 and TNfa promoter polymorphisms in patients with acute arthritis. Special reference to development of chronic spondyloarthropathy
###end article-title 110
###begin article-title 111
A CD14 promoter polymorphism is associated with CD14 expression and Chlamydia-stimulated TNFalpha production
###end article-title 111
###begin article-title 112
###xml 80 100 <span type="species:ncbi:83558">Chlamydia pneumoniae</span>
CD14 promoter polymorphism -159C>T is associated with susceptibility to chronic Chlamydia pneumoniae infection in peripheral blood monocytes
###end article-title 112
###begin article-title 113
###xml 87 108 <span type="species:ncbi:813">Chlamydia trachomatis</span>
###xml 113 134 <span type="species:ncbi:485">Neisseria gonorrhoeae</span>
###xml 149 157 <span type="species:ncbi:9606">patients</span>
Comparison between the LCx probe system and the COBAS AMPLICOR system for detection of Chlamydia trachomatis and Neisseria gonorrhoeae infections in patients attending a clinic for treatment of sexually transmitted diseases in Amsterdam, The Netherlands
###end article-title 113
###begin article-title 114
Diagnosing genital ulcer disease in a clinic for sexually transmitted diseases in Amsterdam, The Netherlands
###end article-title 114
###begin article-title 115
###xml 92 113 <span type="species:ncbi:485">Neisseria gonorrhoeae</span>
Amplified fragment length polymorphism fingerprinting for identification of a core group of Neisseria gonorrhoeae transmitters in the population attending a clinic for treatment of sexually transmitted diseases in Amsterdam, The Netherlands
###end article-title 115
###begin article-title 116
###xml 58 79 <span type="species:ncbi:5722">Trichomonas vaginalis</span>
###xml 84 102 <span type="species:ncbi:2098">Mycoplasma hominis</span>
###xml 106 128 <span type="species:ncbi:2130">Ureaplasma urealyticum</span>
Host and pathogen interaction during vaginal infection by Trichomonas vaginalis and Mycoplasma hominis or Ureaplasma urealyticum
###end article-title 116
###begin article-title 117
###xml 71 76 <span type="species:ncbi:9606">women</span>
Performance of five serological chlamydia antibody tests in subfertile women
###end article-title 117
###begin article-title 118
###xml 54 62 <span type="species:ncbi:9606">patients</span>
How to use Chlamydia antibody testing in subfertility patients
###end article-title 118
###begin article-title 119
###xml 145 166 <span type="species:ncbi:813">Chlamydia trachomatis</span>
Comparison of three commercially available peptide-based immunoglobulin G (IgG) and IgA assays to microimmunofluorescence assay for detection of Chlamydia trachomatis antibodies
###end article-title 119
###begin article-title 120
###xml 38 59 <span type="species:ncbi:813">Chlamydia trachomatis</span>
The inflammatory cytokine response to Chlamydia trachomatis infection is endotoxin mediated
###end article-title 120
###begin article-title 121
###xml 70 91 <span type="species:ncbi:813">Chlamydia trachomatis</span>
###xml 115 141 <span type="species:ncbi:331636">Chlamydophila psittaci 6BC</span>
Endotoxic activity and chemical structure of lipopolysaccharides from Chlamydia trachomatis serotypes E and L2 and Chlamydophila psittaci 6BC
###end article-title 121
###begin article-title 122
Lipopolysaccharide interaction with cell surface Toll-like receptor 4-MD-2: higher affinity than that with MD-2 or CD14
###end article-title 122
###begin article-title 123
Monocytes can phagocytose Gram-negative bacteria by a CD14-dependent mechanism
###end article-title 123
###begin article-title 124
###xml 12 33 <span type="species:ncbi:485">Neisseria gonorrhoeae</span>
Response to Neisseria gonorrhoeae by cervicovaginal epithelial cells occurs in the absence of toll-like receptor 4-mediated signaling
###end article-title 124
###begin article-title 125
###xml 73 78 <span type="species:ncbi:9606">human</span>
Differential expression of Toll-like receptors 2 and 4 in tissues of the human female reproductive tract
###end article-title 125
###begin article-title 126
###xml 76 82 <span type="species:ncbi:9606">humans</span>
Characterization of Toll-like receptors in the female reproductive tract in humans
###end article-title 126
###begin article-title 127
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition
###end article-title 127
###begin article-title 128
###xml 50 55 <span type="species:ncbi:10090">mouse</span>
Cutting edge: naturally occurring soluble form of mouse Toll-like receptor 4 inhibits lipopolysaccharide signaling
###end article-title 128
###begin article-title 129
###xml 67 71 <span type="species:ncbi:10090">mice</span>
Expression of toll-like receptor 4 and endotoxin responsiveness in mice during perinatal period
###end article-title 129
###begin article-title 130
TLR4-dependent recognition of lipopolysaccharide by epithelial cells requires sCD14
###end article-title 130
###begin article-title 131
###xml 20 55 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Correlation between human immunodeficiency virus type 1 RNA levels in the female genital tract and immune activation associated with ulceration of the cervix
###end article-title 131
###begin article-title 132
Binding of lipopeptide to CD14 induces physical proximity of CD14, TLR2 and TLR1
###end article-title 132
###begin article-title 133
###xml 22 42 <span type="species:ncbi:83558">Chlamydia pneumoniae</span>
Non-LPS components of Chlamydia pneumoniae stimulate cytokine production through Toll-like receptor 2-dependent pathways
###end article-title 133
###begin article-title 134
###xml 139 144 <span type="species:ncbi:9606">human</span>
Bacterial lipopolysaccharide induces transforming growth factor beta and hepatocyte growth factor through toll-like receptor 2 in cultured human colon cancer cells
###end article-title 134
###begin article-title 135
Toll-like receptor-2, but not Toll-like receptor-4, is essential for development of oviduct pathology in chlamydial genital tract infection
###end article-title 135
###begin article-title 136
###xml 23 43 <span type="species:ncbi:817">Bacteroides fragilis</span>
###xml 45 66 <span type="species:ncbi:813">Chlamydia trachomatis</span>
###xml 71 93 <span type="species:ncbi:287">Pseudomonas aeruginosa</span>
Lipopolysaccharides of Bacteroides fragilis, Chlamydia trachomatis and Pseudomonas aeruginosa signal via Toll-like receptor 2
###end article-title 136
###begin article-title 137
Lipopolysaccharide recognition: CD14, TLRs and the LPS-activation cluster
###end article-title 137
###begin article-title 138
###xml 75 96 <span type="species:ncbi:813">chlamydia trachomatis</span>
Description of the ICTI consortium: an integrated approach to the study of chlamydia trachomatis infection
###end article-title 138

